Overview
ABCL market data
Price History
ABCL price chart · 1M
- O
- 11.63
- H
- 11.82
- L
- 11.29
- C
- 11.56
- Vol
- 240,978.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $11.63
- Previous Close
- $11.36
- Day High
- $11.82
- Day Low
- $11.29
- 52 Week High
- $12.57
- 52 Week Low
- $3.95
- 7 Day Return
- -6.66%
- 30 Day Return
- +89.51%
- 90 Day Return
- +106.06%
- 1 Year Return
- +139.34%
- Daily Notional Volume
- $2.8M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.49 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.60 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -248.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.75 – $12.58 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.4B · P/B 1.06 · P/S 50.83.
Company News
10 captured
What'sGoing On With AbCellera Biologics Stock On Tuesday?Benzinga · Aug 25, 2026, 6:38 PM
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On TuesdayBenzinga · Aug 25, 2026, 2:03 PM
8-K filing — AbCellera Biologics Inc. (ABCL)SEC EDGAR · Aug 13, 2026, 8:33 PM
AbCellera Prices Oversubscribed $200.0M Offering Of 17,435,897 Common Shares At $9.75 Per ShareBenzinga · Aug 13, 2026, 5:09 AM
What's Going on With AbCellera Biologics Stock On Wednesday?Benzinga · Aug 12, 2026, 5:54 PM
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Aug 12, 2026, 12:06 PM
AbCellera Biologics shares are trading lower after the company announced a $200 million offering.Benzinga · Aug 12, 2026, 11:53 AM
AbCellera Biologics Commences Underwritten Public Offering Of $200M Of Its Common SharesBenzinga · Aug 11, 2026, 8:03 PM
Truist Securities Maintains Buy on AbCellera Biologics, Raises Price Target to $30Benzinga · Aug 11, 2026, 5:30 PM
AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'Benzinga · Aug 10, 2026, 6:12 PM